Introduction
Adult hematopoiesis is a hierarchical system arising from a rare population (<0.01% in bone marrow) of hematopoietic stem cells (HSCs). Properties of HSCs include selfrenewal, extensive proliferative capacity and the ability to generate all lineages of the hematopoietic system. HSCs can be divided into long-term (LT)-HSCs, short-term (ST)-HSCs and multi-potent progenitors (MPPs). LT-HSCs, which are relatively quiescent, provide multi-lineage engraftment over the several months. 1 LT-HSCs can self-renew for the lifetime of the animal and in the mouse, this property can be tested by serial transplantation. 2 LT-HSCs give rise to ST-HSCs and MPPs, which have limited selfrenewal capacity but can rapidly provide multi-lineage repopulation of lethally irradiated recipients. [3] [4] [5] [6] Early engraftment by multi-lineage progenitors is an important but poorly understood process that requires homing to the spleen and bone marrow, rapid proliferation and multi-lineage differentiation within the first few weeks after transplantation.
Expression of the cell surface antigens c-kit and Sca-1 in the absence of lineage markers can be utilised to enrich for HSCs. 7 In vitro assays including the high proliferative potential assay and long-term culture initiating cell assay are based upon the requirement of primitive progenitors for multiple cytokines or stromal cell support. 8, 9 While these assays have been used as surrogate in vitro assays of HSCs, the competitive repopulation assay remains the gold standard. 10, 11 The competitive repopulation assay is a sensitive in vivo assay of that can detect subtle differences in repopulating ability.
Repopulation as early as 3 weeks after transplant reflects the activity of multi-potent progenitors. 12, 13 Although the competitive repopulation assay quantitates function of stem only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From 4 cell populations rather than individual HSCs, it has been validated against limiting dilution analysis as a method of comparing the functional capacity of HSCs from different donor populations. 12, 13 The ability to generate hematopoietic cells of all lineages requires finely controlled homeostatic mechanisms balancing self-renewal, proliferation, lineage commitment, differentiation and cell death. 14 The critical signals and transcription factors that regulate HSC fate are still incompletely understood. Gene deletion studies have identified several transcription factors including SCL (Tal-1/TCL-5), AML1 and GATA-2 that are critical for the development of primitive and definitive hematopoiesis in the embryo. [15] [16] [17] [18] [19] Embryonic lethality has precluded the use of gene-targeted mice to study the role of these genes in the function of adult HSCs. To circumvent this, others and we generated a conditional SCL knockout mouse model to directly examine the role of SCL in adult hematopoiesis. 20, 21 Our initial studies demonstrated that SCL was critical for the growth of BFU-E and Mk-CFC but was dispensable for oligo-lineage granulocyte/macrophage progenitor cells. 20, 21 Others confirmed these results and also demonstrated that SCL was dispensable for HSC activity, raising the possibility that once
HSCs are formed in development, SCL is no longer required for HSC function. 21 In this study, we have used SCL conditional knockout mice to examine HSC function using competitive repopulation assays. We demonstrate that SCL is required for the normal function of multi-potent ST -HSCs. 
Transplantation assays
The competitive repopulation assay was performed as described previously. 12 Bone marrow cells for transplant were harvested after poly(I:C) by flushing femurs and tibias with phosphate-buffered saline/5% fetal bovine serum using a 21-gauge needle 
Results

Stem cell immunophenotype defects in SCL-deleted mice
Using SCL-conditional targeted mice, we have previously shown that SCL was required for normal megakaryopoiesis and erythropoiesis. 20 Deletion of SCL also limited the differentiation potential of multi-potent CFU-S 12 to myeloid cells. 20 To analyse the effect of deleting SCL in HSCs, we enumerated the number of HSCs in SCL-conditional In view the important role for SCL in megakaryopoiesis and erythropoiesis, 20, 21 we were surprised to observe that SCL-deleted (MxSCL 
SCL is required for normal function of multi-lineage repopulating cells
To assess the function of SCL in HSCs, we utilised the competitive repopulation assay.
The advantage of this assay is that the competitor cells remove any selective pressure for only.
For Repopulating abilities of SCL-deleted (MxSCL / ) and heterozygous (MxSCL +/ ) bone marrow for 3 independent transplant assays were calculated as previously only.
For 12, 13 Overall, SCL-deleted bone marrow contained between 4 and 22 fold-less repopulating activity than SCL-heterozygous bone marrow, depending upon which lineage was used for the calculation (Table 1) . The appearance of the multi-lineage defect at 4 weeks favoured a defect at the level of the multi-potent progenitor (MPP) or ST-HSC. 6 Although we cannot exclude multiple defects in more mature lineage restricted progenitors, this is unlikely because we have previously shown that day 7 GM-CFC are normal. 20 An alternate explanation for the transplant defect was a homing defect of SCL-deleted marrow cells. CFSE-labelled bone marrow cells were used to assess homing of SCL-deleted bone marrow cells. 27 Four hours after injection of bone marrow cells, there was no difference in the number of SCLwild type or SCL-deleted cells homing to the spleen (18±4% and 24±3% of cells injected respectively) or bone marrow (5.4±0.4% and 7.4±0.8%). Furthermore, we have previously shown that the number of SCL-deleted CFU-S 12 is, at most, 2-fold reduced. 20 Together with the CFSE-labelling results, this suggests that the early repopulating defect of SCL-deleted marrow cells was unlikely to be explained by a homing defect. Although these experiments cannot exclude impaired homing of a progenitor more immature than the CFU-S 12 , this is unlikely given the data in secondary recipients discussed below.
In summary, in primary transplant recipients there was a defect in MPP or ST-HSC function, with reduced contribution of SCL-deleted cells to myeloid, B-cell, T-cell lineages. This was unlikely to be due to a homing defect of SCL-deleted marrow cells. Comparison of SCL-wild type and SCL-heterozygous donor cell contribution to erythroid cells was performed by a one-sided Student's t-Test. **p<0.01
SCL is not required for self-renewal of HSCs
To examine the function of SCL in self-renewal, we performed serial transplant experiments. After 4 to 6 months, bone marrow was harvested from the primary transplant recipients discussed above and transplanted into lethally irradiated secondary recipients. Secondary recipients were analysed 4 months after transplant ( Figure 3A) . The Although the mean proportion of SCL-deleted thymocytes in secondary recipients was similar to that observed in primary recipients, the proportions were highly variable, with some mice having >95% SCL-deleted T-cells despite very low numbers (<10%) of SCL-deleted myeloid cells. The defect of myeloid repopulation by SCL-deleted HSCs and the preference for SCL-deleted T-cells were confirmed by Southern blot ( Figure 3C ).
Together, the results of serial transplantation suggested that the defect of SCLdeleted cells in long-term repopulation was persistent and cell-intrinsic. The increased numbers of SCL-null T-cells in secondary recipients raised the possibility that loss of SCL favored T-lymphoid differentiation of HSCs.
only.
For 
Rescue of the repopulating defect by SCL-wild type hematopoiesis
Mikkola et al. recently reported that SCL-deleted HSCs had normal function. 21 In an attempt to reconcile this observation with our data showing a significant transplantation defect, we assayed SCL-deleted HSCs using their experimental design ( Figure 4A ). Bone 
Discussion
We used the competitive repopulation assay to demonstrate a severe multi-lineage repopulating defect of SCL-deleted bone marrow cells. The appearance of the defect at 4 weeks suggests that SCL is required for the function of a multi-lineage progenitor such as an MPP or ST-HSC, cells required for rapid multi-lineage engraftment. 7, 28 Although the mechanism of the repopulation defect remains to be elucidated, SCL is unlikely to be required for homing of HSCs because numbers of CFU-S 12 are not reduced more than 2-fold, 20 normal numbers of SCL-null bone marrow cells home to the spleen and bone marrow within 4 hours, and the transplant defect does not worsen in secondary recipients ( Figure 3A ). The defect was not worse at 16 weeks nor in secondary recipients ( Figure   3B ), suggesting that SCL is not required for properties of LT-HSCs including selfrenewal.
Our data raises the possibility that SCL is required for proliferation and/or differentiation of HSCs. The observation that non-deleted SCL cells do not expand in the bone marrow of SCL-deleted mice ( Figure 1A) 21 Relative levels of transcription factors are likely to regulate the cell fate of multi-potent progenitors. For example, relative levels of PU-1 and GATA-1 appear to regulate myeloid cell fate. 30 It is possible that loss of the transcription factor, SCL, favours the formation of lymphoid progenitors by increasing the number of E2A homodimers. The opposite scenario (increased levels of SCL resulting in reduced E2A homodimers) is a proposed mechanism of inhibiting T-cell differentiation. 31 Competitive limiting dilution analysis or clonal analyses of multi-potent cell lines derived from SCL-deleted mice would be necessary to more clearly define the role of SCL in lineage commitment. Further detailed analysis of these conditionally targeted mice will further define the function of SCL in adult HSCs.
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